In:
Cancer, Wiley, Vol. 122, No. 13 ( 2016-07), p. 2041-2049
Abstract:
Stereotactic body radiotherapy achieves high local control (3‐year local control rate, 96.3%) and overall survival with acceptable toxicities for patients who have a solitary hepatocellular carcinoma (HCC), despite rather stringent conditions. Stereotactic body radiotherapy can be effective against solitary HCC in treatment‐naive, intrahepatic failure, residual disease, and recurrent settings, taking advantage of its distinctive characteristics.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v122.13
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink